Cerecor Inc (CERC) Short Interest Down 33.8% in January
Cerecor Inc (NASDAQ:CERC) was the recipient of a large drop in short interest in January. As of January 12th, there was short interest totalling 777,488 shares, a drop of 33.8% from the December 29th total of 1,174,319 shares. Currently, 4.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 493,309 shares, the days-to-cover ratio is currently 1.6 days.
Cerecor (NASDAQ CERC) opened at $3.47 on Monday. Cerecor has a twelve month low of $0.34 and a twelve month high of $4.25. The company has a market cap of $90.41 and a price-to-earnings ratio of 9.38.
Cerecor (NASDAQ:CERC) last released its earnings results on Monday, November 6th. The company reported $0.52 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.24) by $0.76. Cerecor had a net margin of 51.71% and a return on equity of 212.90%. equities analysts predict that Cerecor will post 0.83 earnings per share for the current year.
In related news, major shareholder Armistice Capital Master Fund acquired 45,200 shares of the stock in a transaction dated Friday, November 24th. The shares were purchased at an average price of $1.20 per share, for a total transaction of $54,240.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Armistice Capital, Llc acquired 35,200 shares of the stock in a transaction dated Wednesday, November 22nd. The shares were bought at an average price of $1.20 per share, for a total transaction of $42,240.00. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 90,685 shares of company stock worth $108,984. Corporate insiders own 10.70% of the company’s stock.
A hedge fund recently bought a new stake in Cerecor stock. Acadian Asset Management LLC bought a new stake in shares of Cerecor Inc (NASDAQ:CERC) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 60,719 shares of the company’s stock, valued at approximately $194,000. Acadian Asset Management LLC owned about 0.23% of Cerecor as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 64.03% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This story was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.watchlistnews.com/cerecor-inc-cerc-short-interest-down-33-8-in-january/1829838.html.
Cerecor, Inc is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment.
Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.